Knowing what to ask your doctor about your CLL treatment can help you feel more comfortable with your diagnosis and know what to expect for the future. There are many treatment options ...

Different chronic lymphocytic leukemia (CLL) treatments and their side effects can be dehydrating. You can take steps to reduce the risk of dehydration. If you’re not able to keep up with your ...

A study in Cancer compared the accuracy of five risk scores for time to treatment in CLL, including the IPS-E, CR0, AIPS-E, ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

Jaypirca is a targeted therapy for CLL and other specific cancers. It is known as a Bruton’s tyrosine kinase inhibitor (BTK inhibitor). BTK is an enzyme that helps certain types of cancer cells ...

The following is a summary of "BCL-2 dependence is a favorable predictive marker of response to therapy for chronic ...

Immunotherapy research primarily focuses on improving the body’s immune system’s recognition of cancer cells. However, ...

Ibrutinib remains a key treatment for relapsed chronic lymphocytic leukemia (CLL), but findings suggest that combining it ...

Researchers sought to determine whether zanubrutinib is more beneficial than ibrutinib in patients with CLL/SLL.